28.41
-2.38(-7.73%)
Currency In USD
Previous Close | 30.79 |
Open | 30.5 |
Day High | 30.78 |
Day Low | 28.25 |
52-Week High | 31.12 |
52-Week Low | 7.75 |
Volume | 124,161 |
Average Volume | 142,739 |
Market Cap | 217.97M |
PE | -4.89 |
EPS | -5.81 |
Moving Average 50 Days | 24.97 |
Moving Average 200 Days | 16.9 |
Change | -2.38 |
If you invested $1000 in Assembly Biosciences, Inc. (ASMB) 10 years ago, it would be worth $249.74 as of October 21, 2025 at a share price of $28.41. Whereas If you bought $1000 worth of Assembly Biosciences, Inc. (ASMB) shares 5 years ago, it would be worth $152.94 as of October 21, 2025 at a share price of $28.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Assembly Biosciences Announces Upcoming Investor Conference Participation
GlobeNewswire Inc.
Oct 14, 2025 11:00 AM GMT
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the company will participate
Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe
GlobeNewswire Inc.
Oct 10, 2025 12:00 PM GMT
– Late-breaking oral presentation highlights interim Phase 1b data reported earlier this year for two cohorts in participants with recurrent genital herpes – – Statistically significant reductions in HSV-2 shedding rate, high viral load shedding rat
Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
GlobeNewswire Inc.
Aug 08, 2025 12:05 PM GMT
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (“Assembly Bio”) (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced the pricing of a